Contrast Clearance Analysis for Differentiating Tumor From Treatment Effects
Yael Mardor, PhD, from the Chaim Sheba Medical Center in Israel discusses MRI-based treatment response assessment maps for differentiating tumor from treatment effects in patients with brain tumors. She begins by outlining the delayed contract extravasation methodology of the software Elements Contrast Clearance Analysis. She then explains the rationale and histological validation of the methodology before delving into specific case examples and discussed its place as a tool for clinicial decision-making.
About the speaker
Mardor Yael, PhD
The Chaim Medical Center, Israel
Clinical Advantages of Elements with ExacTrac
Benefits of Implementing Automation and Outcome Measures in Modern Radiosurgery Practices
Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues...
Early Validation of ExacTrac Dynamic: New Features and Accuracy of the System
Evaluation of Stereotactic Techniques for Serial or Concomitant Treatment
Contrast Clearance Analysis for Differentiating Tumor from Treatment Effects
Impact of Margins for Single Isocenter Multiple Target Treatments
Early Validation of ExacTrac Dynamic: New Features & Accuracy of the System
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login